A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas

Cytogenetic and Genome Research

Volumn 101, Issue 2, 2003, Pages 113-117

  Meiboom, M ^a   Murua Escobar, H ^a   Pentimalli, F ^b   Fusco, A ^b   Belge, G ^a   Bullerdiek, J ^a  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN; PROTEIN ZNF331; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CHROMOSOME 13; CHROMOSOME 19Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; FOLLICULAR THYROID ADENOMA; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR CLONING; MOLECULAR WEIGHT; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; THYROID ADENOMA; THYROID CARCINOMA; THYROID FOLLICLE; TUMOR CELL LINE; ZNF331 GENE;

ADENOMA; BLOTTING, NORTHERN; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; DNA-BINDING PROTEINS; HUMANS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA SPLICING; THYROID NEOPLASMS; TISSUE DISTRIBUTION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC;

EID: 0344155126     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074165     Document Type: Article

References (21)

1. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 25:3389-3402 (1997).
2. Belge G, Kazmierczak B, Meyer-Bolte K, Bartnitzke S, Bullerdiek J: Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation t(3;12) is not sufficient for direct immortalization. Cell Biol Int Rep 16:339-347 (1992).
3. Belge B, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S, Bullerdiek J: Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42-48 (1998).
4. Bellefroid EJ, Marine JC, Ried T, Lecocq PJ, Riviere M, Amemiya C, Poncelet DA, Coulie PG, de Jong P, Szpirer C: Clustered organization of homologous KRAB zinc-finger genes with enhanced expression in human T lymphoid cells. EMBO J 12:1363-1374 (1993).
5. Cassoni P, Muccioli G, Marrocco T, Volante M, Allia E, Ghigo E, Deghenghi R, Papotti M: Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin. J Endocrinol Invest 25:362-368 (2002).
6. Cerutti J, Trapasso F, Battaglia C, Zhang L, Martelli ML, Visconti R, Berlingieri MT, Fagin JA, Santoro M, Fusco A: Block of c-myc expression by anti-sense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines. Clin Cancer Res 2:119-126 (1996).
7. Eichler EE, Hoffman SM, Adamson AA, Gordon LA, McCready P, Lamerdin JE, Mohrenweiser HW: Complex beta-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12. Genome Res 8:791-808 (1998).
8. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP: High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91:179-184(1993).
9. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13 (1983).
10. Fredericks WJ, Ayyanathan K, Herlyn M, Friedman JR, Rauscher FJ III: An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Mol Cell Biol 20:5019-5031(2000).
11. Friedman JR, Fredericks WJ, Jensen DE, Speicher DW, Huang XP, Neilson EG, Rauscher FJ III: KAP-1, a novel corepressor for the highly conserved KRAB repression domain. Genes Dev 10:2067-2078 (1996).
12. Kim SS, Chen YM, O'Leary E, Witzgall R, Vidal M, Bonventre JV: A novel member of the RING finger family, KRIP-1, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc natl Acad Sci, USA 93:15299-15304 (1996).
13. Margolin JF, Friedman JR, Meyer WK, Vissing H, Thiesen HJ, Rauscher FJ III: Kruppel-associated boxes are potent transcriptional repression domains. Proc natl Acad Sci, USA 91:4509-4513 (1994).
14. Nawrath M, Pavlovic J, Moelling K: Inhibition of human hematopoietic tumor formation by targeting a repressor Myb-KRAB to DNA. Cancer Gene Ther 7:963-972 (2000).
15. Pang XP, Hershman JM, Chung M, Pekary AE: Characterization of tumor necrosis factor-alpha receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 125:1783-1788 (1989).
16. Rippe V, Belge G, Meiboom M, Kazmierczak B, Fusco A, Bullerdiek J: A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors. Genes Chrom Cancer 26: 229-236 (1999).
17. Shannon M, Ashworth LK, Mucenski ML, Lamerdin JE, Branscomb E, Stubbs L: Comparative analysis of a conserved zinc finger gene cluster on human chromosome 19q and mouse chromosome 7. Genomics 33:112-120 (1996).
18. Vissing H, Meyer WK, Aagaard L, Tommerup N, Thiesen HJ: Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins. FEBS Lett 369:153-157 (1995).
19. Witzgall R, O'Leary E, Leaf A, Onaldi D, Bonventre JV: The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc natl Acad Sci, USA 91: 4514-4518 (1994).
20. Wu H, Zhang S, Qiu W, Zhang G, Xia Q, Xiao C, Huang X, Huang M, Agen P, Fan T, Yang J, Milunsky A: Isolation, characterization, and mapping of a novel human KRAB zinc finger protein encoding gene ZNF463. Biochim biophys Acta 1518:190-193 (2001).
21. Zeki K, Nakano Y, Inokuchi N, Watanabe K, Morimo-to I, Yamashita U, Eto S: Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIM 1. J Clin Endocrinol Metab 76:127-133 (1993).